⌘K

Login Start Free

Home/Filings/4/0001213900-25-019672

4//SEC Filing

Bodenstedt Matthias 4

Accession 0001213900-25-019672

CIK 0001821586other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:06 PM ET

Size

4.9 KB

Accession

0001213900-25-019672

Insider Transaction Report

Form 4

Period: 2025-02-27

MoonLake ImmunotherapeuticsMLTX

Bodenstedt Matthias

Chief Financial Officer

Transactions

Award
Class A ordinary shares, par value $0.0001 per share
2025-02-27+95,763→ 616,666 total

Footnotes (1)

[F1]Represents shares of restricted stock that vest in four equal annual installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

4
ownership.xmlPrimary

Issuer

MoonLake Immunotherapeutics

CIK 0001821586

Entity typeother

Related Parties

1

filerCIK 0001920545

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 9:06 PM ET
Size: 4.9 KB

View on SEC.gov